ESC 365 - Coronary revascularisation provides no meaningful clinical benefit over optimal medical therapy in patients with stable ischaemic heart failure - CONTRA

HFA Premium Access

Coronary revascularisation provides no meaningful clinical benefit over optimal medical therapy in patients with stable ischaemic heart failure - CONTRA

Session: GRAND DEBATE I - Drugs or interventions - The beat goes on

Topic: Treatment, Other

Speaker: Professor E. Velazquez (New Haven, US)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Professor Eric Velazquez

Yale School of Medicine, New Haven (United States of America)

8 presentations

1 follower

15 more presentations in this session

Positioning of the topic

Speaker: Professor E. Braunwald (Boston, US)

Opening question

Coronary revascularisation provides no meaningful clinical benefit over optimal medical therapy in patients with stable ischaemic heart failure - PRO

Speaker: Professor J. Cleland (Glasgow, GB)

Rebuttal - PRO

Rebuttal - CONTRA

Access the full session

GRAND DEBATE I - Drugs or interventions - The beat goes on

Speakers: Professor E. Velazquez, Professor E. Braunwald, Professor J. Cleland

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources